PediSepsisAR: Augmented Reality in Pediatric Septic Shock Simulation (1090-003575) (Developmental Research Projects: Resuscitation, Clinical Outcomes, Cultural Fluency (By Invitation Only))
Start time: Thursday, February 4, 2021 End time: Thursday, February 4, 2021, 4:00 PM Session Type: Research Study Development and Presentation Program Abstracts
Septic shock is a potentially life-threatening condition requiring prompt recognition and aggressive resuscitation to optimize patient outcomes. Pediatric trainees are currently taught to recognize and treat septic shock in simulated scenarios with the use of high-fidelity manikins. However, their ability to receive real-time feedback in these simulations is limited. Augmented reality (AR) allows for the delivery of real-time feedback by enabling participants to see the impact of administering intravenous (IV) fluid to a manikin through a digital model of the circulatory system. We hypothesize that incorporating our AR application, PediSepsisAR, will improve participant speed of fluid administration, and will specifically increase the participants’ awareness of patient blood flow and encourage them to push fluids faster.
Through partnership with BrickSimple, a Philadelphia based software company, we have adapted an existing prototype, CPReality, to create PediSepsisAR. CPReality integrates with the HoloLens headset to depict a digital model of the circulatory system that can be overlaid on a simulation manikin. BrickSimple enabled this prototype to interact with a potentiometer embedded in the IV fluid syringe, thus the digital circulation changes with fluid administration. In our study, we will enroll a convenience sample of residents, fellows, attending physicians, nurse practitioners, and pediatric nurses. Enrolled participants will complete a pre-study questionnaire requesting demographic data and prior experience. They will be randomized to administer fluid to a manikin either with or without the use of PediSepsisAR. Those randomized to PediSepsisAR will wear the HoloLens during the simulation and complete a post-study questionnaire regarding how PediSepsisAR may have impacted their performance.
On analysis, we will determine the proportion of participants in which all data elements are successfully captured and will compare median time to administer 20ml/kg, 40 ml/kg, and 60 ml/kg IV fluids in the simulation exercises. The descriptive data gathered through our proposed pilot study would then be used to estimate effect size such that we could adequately power a clinical trial comparing the rates of intravenous fluid administration during PediSepsisAR and simulation alone. Additionally, we plan to quantitatively and qualitatively evaluate the results of the post-study questionnaires completed by those in the PediSepsisAR group.
Co-Presenter: Ethan Vorel, The Children's Hospital of Philadelphia About the co-presenter: I am currently a second year resident physician at The Children's Hospital of Philadelphia.
Disclosure: No financial relationships with ineligible companies.